Zheng Zhu

The Mechanism of Anti–PD-L1 Antibody Efficacy against PD-L1–Negative Tumors Identifies NK Cells Expressing PD-L1 as a Cytolytic Effector

Wenjuan Dong, Xiaojin Wu, Shoubao Ma et al. · Cancer Discovery · 2019 · 288 citations · Full text

Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling

Hu Chen, Hong Li, Jinjun Li et al. · Carcinogenesis · 2008 · 142 citations · Full text

Chemoprevention Strategy, Intrinsic Drug Resistance, Immunology +17

Off-the-Shelf Prostate Stem Cell Antigen–Directed Chimeric Antigen Receptor Natural Killer Cell Therapy to Treat Pancreatic Cancer

Kun‐Yu Teng, Anthony G. Mansour, Zheng Zhu et al. · Gastroenterology · 2022 · 121 citations · Full text

Treat Pancreatic Cancer, Cell Therapy, Pancreatic Cancer +8

The IL-15–AKT–XBP1s signaling pathway contributes to effector functions and survival in human NK cells

Yufeng Wang, Yibo Zhang, Ping Yi et al. · Nature Immunology · 2018 · 106 citations

Cytokine, Human Nk Cells, Immunology +8

Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer

Shaoming Zhu, A-Hong Ma, Zheng Zhu et al. · Journal for ImmunoTherapy of Cancer · 2021 · 77 citations · Full text